Evaluation of barriers to referral for cancer predisposition syndromes in pediatric oncology patients in the United States.
cancer predisposition syndrome
genetic counseling
referral barrier
risk assessment
Journal
Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
13
01
2022
received:
14
01
2021
accepted:
24
01
2022
pubmed:
12
2
2022
medline:
9
8
2022
entrez:
11
2
2022
Statut:
ppublish
Résumé
Cancer predisposition syndromes (CPS) are underdiagnosed in the pediatric population, though the diagnosis of a CPS has important implications for the child and their family. CPS are often diagnosed by geneticists or oncologists with expertise in CPS following a malignancy. This requires a member of the care team, most commonly, the treating oncologist to suspect a CPS and refer the patient for CPS assessment. An online survey was distributed to members of the Children's Oncology Group to elucidate current referral practices and barriers to referral for patients suspected to have a CPS. Of the 183 respondents, 86.1% was pediatric oncologists and most (68.5%) used formal guidelines to aid in assessment. Most respondents indicated they would rarely refer patients with tumors highly associated with CPS for genetic assessment. Participants were more likely to refer patients with malignancy and additional features of a CPS than for a specific type of cancer, despite the use of guidelines. Parent knowledge of family history was considered the most challenging barrier to obtaining a family history, though a thorough pedigree was not consistently elicited. Providers indicated the most significant barrier to referral for CPS assessment was priority given the patient's immediate care needs. Identification of these barriers provides direction to focus efforts to increase referrals. Provider education about CPS, clear referral guidelines, and implementation of or increased collaboration with a genetic counselor in the pediatric oncology clinic may encourage CPS assessment and enable oncologists to focus on the patient's immediate care needs.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
901-911Informations de copyright
© 2022 National Society of Genetic Counselors.
Références
Al-Habsi, H., Lim, J. N., Chu, C. E., & Hewison, J. (2008). Factors influencing the referrals in primary care of asymptomatic patients with a family history of cancer. Genetics in Medicine, 10(10), 751-757. https://doi.org/10.1097/GIM.0b013e318185212a
Batra, S., Valdimarsdottir, H., McGovern, M., Itzkowitz, S., & Brown, K. (2002). Awareness of genetic testing for colorectal cancer predisposition among specialists in gastroenterology. American Journal of Gastroenterology, 97(3), 729-733. https://doi.org/10.1111/j.1572-0241.2002.05556.x
Brandt, R., Ali, Z., Sabel, A., McHugh, T., & Gilman, P. (2008). Cancer genetics evaluation: Barriers to and improvements for referral. Genetic Testing, 12(1), 9-12. https://doi.org/10.1089/gte.2007.0036
Burt, R. W., Bishop, D. T., Lynch, H. T., Rozen, P., & Winawer, S. J. (1990). Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bulletin of the World Health Organization, 68(5), 655-665.
Carroll, J. C., Cappelli, M., Miller, F., Wilson, B. J., Grunfeld, E., Peeters, C., Hunter, A., Gilpin, C., & Prakash, P. (2008). Genetic services for hereditary breast/ovarian and colorectal cancers - physicians' awareness, use and satisfaction. Community Genetics, 11(1), 43-51. https://doi.org/10.1159/000111639
Chang, W., Brohl, A. S., Patidar, R., Sindiri, S., Shern, J. F., Wei, J. S., Song, Y. K., Yohe, M. E., Gryder, B., Zhang, S., Calzone, K. A., Shivaprasad, N., Wen, X., Badgett, T. C., Miettinen, M., Hartman, K. R., League-Pascual, J. C., Trahair, T. N., Widemann, B. C., … Khan, J. (2016). Multi dimensional clinomics for precision therapy of children and adolescent young adults with relapsed and refractory cancer: A report from the center for cancer research. Clinical Cancer Research, 22(15), 3810-3820. https://doi.org/10.1158/1078-0432.CCR-15-2717
Copson, E. R., Maishman, T. C., Tapper, W. J., Cutress, R. I., Greville-Heygate, S., Altman, D. G., Eccles, B., Gerty, S., Durcan, L. T., Jones, L., Evans, D. G., Thompson, A. M., Pharoah, P., Easton, D. F., Dunning, A. M., Hanby, A., Lakhani, S., Eeles, R., Gilbert, F. J., … Eccles, D. M. (2018). Germline BRCA mutation and outcome in young-onset breast cancer (POSH): A prospective cohort study. The Lancet Oncology, 19(2), 169-180. https://doi.org/10.1016/S1470-2045(17)30891-4
Diamonstein, C., Stevens, B., Shahrukh Hashmi, S., Refuerzo, J., Sullivan, C., & Hoskovec, J. (2018). Physicians' awareness and utilization of genetic services in Texas. Journal of Genetic Counseling, 27(4), 968-977. https://doi.org/10.1007/s10897-017-0199-z
Diets, I. J., Waanders, E., Ligtenberg, M. J., van Bladel, D. A. G., Kamping, E. J., Hoogerbrugge, P. M., Hopman, S., Olderode-Berends, M. J., Gerkes, E. H., Koolen, D. A., Marcelis, C., Santen, G. W., van Belzen, M. J., Mordaunt, D., McGregor, L., Thompson, E., Kattamis, A., Pastorczak, A., Mlynarski, W., … Jongmans, M. C. (2018). High yield of pathogenic germline mutations causative or likely causative of the cancer phenotype in selected children with cancer. Clinical Cancer Research, 24(7), 1594-1603. https://doi.org/10.1158/1078-0432.CCR-17-1725
Druker, H., Zelley, K., McGee, R. B., Scollon, S. R., Kohlmann, W. K., Schneider, K. A., & Wolfe Schneider, K. (2017). Genetic counselor recommendations for cancer predisposition evaluation and surveillance in the pediatric oncology patient. Clinical Cancer Research, 23(13), e91-e97. https://doi.org/10.1158/1078-0432.CCR-17-0834
Febbraro, T., Robison, K., Wilbur, J. S., Laprise, J., Bregar, A., Lopes, V., Legare, R., & Stuckey, A. (2015). Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals. Gynecologic Oncology, 138(1), 109-114. https://doi.org/10.1016/j.ygyno.2015.04.029
Fiala, E. M., Jayakumaran, G., Mauguen, A., Kennedy, J. A., Bouvier, N., Kemel, Y., Fleischut, M. H., Maio, A., Salo-Mullen, E. E., Sheehan, M., Arnold, A. G., Latham, A., Carlo, M. I., Cadoo, K., Murkherjee, S., Slotkin, E. K., Trippett, T., Glade Bender, J., Meyers, P. A., … Walsh, M. F. (2021). Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. Nature Cancer, 2(3), 357-365. https://doi.org/10.1038/s43018-021-00172-1
Ford, D., Easton, D. F., & Peto, J. (1995). Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. American Journal of Human Genetics, 57(6), 1457-1462.
Garcia, C., Harrison, K., Ring, K. L., Sullivan, M. W., Rauh, L. A., & Modesitt, S. C. (2019). Genetic counseling referral for ovarian cancer patients: A call to action. Familial Cancer, 18(3), 303-309. https://doi.org/10.1007/s10689-019-00129-5
Gröbner, S. N., Worst, B. C., Weischenfeldt, J., Buchhalter, I., Kleinheinz, K., Rudneva, V. A., Johann, P. D., Balasubramanian, G. P., Segura-Wang, M., Brabetz, S., Bender, S., Hutter, B., Sturm, D., Pfaff, E., Hübschmann, D., Zipprich, G., Heinold, M., Eils, J., Lawerenz, C., … Pfister, S. M. (2018). The landscape of genomic alterations across childhood cancers. Nature, 555(7696), 321-327. https://doi.org/10.1038/nature25480
Hampel, H., Bennett, R. L., Buchanan, A., Pearlman, R., & Wiesner, G. L. & Guideline Development Group of the American College of Medical Genetics and Genomics Professional Practice and Guidelines Committee and the National Society of Genetic Counselors Practice Guidelines Committee. (2015). A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: Referral indications for cancer predisposition assessment. Genetics in Medicine, 17(1), 70-87. https://doi.org/10.1038/gim.2014.147
Hoskovec, J. M., Bennett, R. L., Carey, M. E., DaVanzo, J. E., Dougherty, M., Hahn, S. E., LeRoy, B. S., O’Neal, S., Richardson, J. G., & Wicklund, C. A. (2018). Projecting the supply and demand for certified genetic counselors: A workforce study. Journal of Genetic Counseling, 27(1), 16-20. https://doi.org/10.1007/s10897-017-0158-8
Houwink, E. J., van Luijk, S. J., Henneman, L., van der Vleuten, C., Jan Dinant, G., & Cornel, M. C. (2011). Genetic educational needs and the role of genetics in primary care: A focus group study with multiple perspectives. BMC Family Practice, 12, 5. https://doi.org/10.1186/1471-2296-12-5
Hudson, P., Zajo, K., Gerhardt, C. A., Stanek, J., & Varga, E. (2019). Defining the role of a genetic counselor within pediatric hematology and oncology comprehensive care teams: Perspectives of the provider team and patients. Journal of Genetic Counseling, 28(6), 1139-1147. https://doi.org/10.1002/jgc4.1164
Jongmans, M. C., Loeffen, J. L., Waanders, E., Hoogerbrugge, P. M., Ligtenberg, M. J., Kuiper, R. P., & Hoogerbrugge, N. (2016). Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool. European Journal of Medical Genetics, 59(3), 116-125. https://doi.org/10.1016/j.ejmg.2016.01.008
Kentwell, M., Dow, E., Antill, Y., Wrede, C. D., McNally, O., Higgs, E., Hamilton, A., Ananda, S., Lindeman, G. J., & Scott, C. L. (2017). Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics. Gynecologic Oncology, 145(1), 130-136. https://doi.org/10.1016/j.ygyno.2017.01.030
Kline, C. N., Joseph, N. M., Grenert, J. P., van Ziffle, J., Talevich, E., Onodera, C., Aboian, M., Cha, S., Raleigh, D. R., Braunstein, S., Torkildson, J., Samuel, D., Bloomer, M., Campomanes, A. G. D. A., Banerjee, A., Butowski, N., Raffel, C., Tihan, T., Bollen, A. W., … Solomon, D. A. (2017). Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro-Oncology, 19, 699-709. https://doi.org/10.1093/neuonc/now254
Knapke, S., Nagarajan, R., Correll, J., Kent, D., & Burns, K. (2012). Hereditary cancer risk assessment in a pediatric oncology follow-up clinic. Pediatric Blood & Cancer, 58(1), 85-89. https://doi.org/10.1002/pbc.23283
Liang, M. I., Wong, D. H., Walsh, C. S., Farias-Eisner, R., & Cohen, J. G. (2018). Cancer genetic counseling and testing: perspectives of epithelial ovarian cancer patients and gynecologic oncology healthcare providers. Journal of Genetic Counseling, 27(1), 177-186. https://doi.org/10.1007/s10897-017-0135-2
Lu, K. H., Wood, M. E., Daniels, M., Burke, C., Ford, J., & Kauff, N. D. & American Society of Clinical, O (2014). American Society of Clinical Oncology Expert Statement: Collection and use of a cancer family history for oncology providers. Journal of Clinical Oncology, 32(8), 833-840. https://doi.org/10.1200/JCO.2013.50.9257
Malkin, D., Nichols, K. E., Schiffman, J. D., Plon, S. E., & Brodeur, G. M. (2017). The future of surveillance in the context of cancer predisposition: through the murky looking glass. Clinical Cancer Research, 23(21), e133-e137. https://doi.org/10.1158/1078-0432.CCR-17-2026
Mody, R. J., Wu, Y.-M., Lonigro, R. J., Cao, X., Roychowdhury, S., Vats, P., Frank, K. M., Prensner, J. R., Asangani, I., Palanisamy, N., Dillman, J. R., Rabah, R. M., Kunju, L. P., Everett, J., Raymond, V. M., Ning, Y. U., Su, F., Wang, R., Stoffel, E. M., … Chinnaiyan, A. M. (2015). Integrative clinical sequencing in the management of refractory or relapsed cancer in youth. JAMA, 314(9), 913-925. https://doi.org/10.1001/jama.2015.10080
Narod, S. A., Stiller, C., & Lenoir, G. M. (1991). An estimate of the heritable fraction of childhood cancer. British Journal of Cancer, 63(6), 993-999. https://doi.org/10.1038/bjc.1991.216
Oberg, J. A., Glade Bender, J. L., Sulis, M. L., Pendrick, D., Sireci, A. N., Hsiao, S. J., Turk, A. T., Dela Cruz, F. S., Hibshoosh, H., Remotti, H., Zylber, R. J., Pang, J., Diolaiti, D., Koval, C., Andrews, S. J., Garvin, J. H., Yamashiro, D. J., Chung, W. K., Emerson, S. G., … Kung, A. L. (2016). Implementation of next generation sequencing into pediatric hematology-oncology practice: Moving beyond actionable alterations. Genome Medicine, 8(1), 133. https://doi.org/10.1186/s13073-016-0389-6
Parsons, D. W., Roy, A., Yang, Y., Wang, T., Scollon, S., Bergstrom, K., Kerstein, R. A., Gutierrez, S., Petersen, A. K., Bavle, A., Lin, F. Y., López-Terrada, D. H., Monzon, F. A., Hicks, M. J., Eldin, K. W., Quintanilla, N. M., Adesina, A. M., Mohila, C. A., Whitehead, W., … Plon, S. E. (2016). Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors. JAMA Oncol, 2(5), 616-624. https://doi.org/10.1001/jamaoncol.2015.5699
Prete, F. P., Abdel-Aziz, T., Morkane, C., Brain, C., & Kurzawinski, T. R. & Group, M. E. N. i. C. U. C (2018). Prophylactic thyroidectomy in children with multiple endocrine neoplasia type 2. British Journal of Surgery, 105(10), 1319-1327. https://doi.org/10.1002/bjs.10856
Prochniak, C. F., Martin, L. J., Miller, E. M., & Knapke, S. C. (2012). Barriers to and motivations for physician referral of patients to cancer genetics clinics. Journal of Genetic Counseling, 21(2), 305-325. https://doi.org/10.1007/s10897-011-9401-x
Rinke, M. L., Mikat-Stevens, N., Saul, R., Driscoll, A., Healy, J., & Tarini, B. A. (2014). Genetic services and attitudes in primary care pediatrics. American Journal of Medical Genetics. Part A, 164A(2), 449-455. https://doi.org/10.1002/ajmg.a.36339
Ripperger, T., Bielack, S. S., Borkhardt, A., Brecht, I. B., Burkhardt, B., Calaminus, G., Debatin, K.-M., Deubzer, H., Dirksen, U., Eckert, C., Eggert, A., Erlacher, M., Fleischhack, G., Frühwald, M. C., Gnekow, A., Goehring, G., Graf, N., Hanenberg, H., Hauer, J., … Kratz, C. P. (2017). Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology. American Journal of Medical Genetics. Part A, 173(4), 1017-1037. https://doi.org/10.1002/ajmg.a.38142
Rolnick, S. J., Rahm, A. K., Jackson, J. M., Nekhlyudov, L., Goddard, K. A. B., Field, T., McCarty, C., Nakasato, C., Roblin, D., Anderson, C. P., & Valdez, R. (2011). Barriers in identification and referral to genetic counseling for familial cancer risk: The perspective of genetic service providers. Journal of Genetic Counseling, 20(3), 314-322. https://doi.org/10.1007/s10897-011-9351-3
Russo, S., Warby, M., Tucker, K. M., Wakefield, C. E., & Cohn, R. J. (2017). Importance of updating family cancer history in childhood cancer survivors. Familial Cancer, 16(4), 605-610. https://doi.org/10.1007/s10689-017-9988-7
Saul, R. A., Trotter, T., Sease, K., & Tarini, B. (2017). Survey of family history taking and genetic testing in pediatric practice. Journal of Community Genetics, 8(2), 109-115. https://doi.org/10.1007/s12687-016-0291-3
Senter, L., O'Malley, D. M., Backes, F. J., Copeland, L. J., Fowler, J. M., Salani, R., & Cohn, D. E. (2017). Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care. Gynecologic Oncology, 147(1), 110-114. https://doi.org/10.1016/j.ygyno.2017.07.141
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram-Baptiste, D., Saslow, D., & Wender, R. C. (2019). Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians, 69(3), 184-210. https://doi.org/10.3322/caac.21557
Vig, H. S., Armstrong, J., Egleston, B. L., Mazar, C., Toscano, M., Bradbury, A. R., Daly, M. B., & Meropol, N. J. (2009). Cancer genetic risk assessment and referral patterns in primary care. Genetic Testing and Molecular Biomarkers, 13(6), 735-741. https://doi.org/10.1089/gtmb.2009.0037
Villani, A., Shore, A., Wasserman, J. D., Stephens, D., Kim, R. H., Druker, H., Gallinger, B., Naumer, A., Kohlmann, W., Novokmet, A., Tabori, U., Tijerin, M., Greer, M.-L., Finlay, J. L., Schiffman, J. D., & Malkin, D. (2016). Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. The Lancet Oncology, 17(9), 1295-1305. https://doi.org/10.1016/S1470-2045(16)30249-2
Wood, M. E., Stockdale, A., & Flynn, B. S. (2008). Interviews with primary care physicians regarding taking and interpreting the cancer family history. Family Practice, 25(5), 334-340. https://doi.org/10.1093/fampra/cmn053
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., Wilkinson, M. R., Vadodaria, B., Chen, X., McGee, R. B., Hines-Dowell, S., Nuccio, R., Quinn, E., Shurtleff, S. A., Rusch, M., … Downing, J. R. (2015). Germline mutations in predisposition genes in pediatric cancer. New England Journal of Medicine, 373(24), 2336-2346. https://doi.org/10.1056/NEJMoa1508054